Pharmacological inhibition of fatty acid oxidation reduces atherosclerosis progression by suppression of macrophage NLRP3 inflammasome activationPhilipp J. Hohensinner, Walter S. Speidl, Patrick Haider et al.|Biochemical Pharmacology|2021Cited by 25